Illumina Stock Price, News & Analysis (NASDAQ:ILMN)

$229.20 +0.07 (+0.03 %)
(As of 02/20/2018 02:12 PM ET)
Previous Close$229.20
Today's Range$227.03 - $230.95
52-Week Range$158.02 - $248.97
Volume701,600 shs
Average Volume1.04 million shs
Market Capitalization$33.69 billion
P/E Ratio38.41
Dividend YieldN/A
Beta0.92

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Receive ILMN News and Ratings via Email

Sign-up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryLife Sciences Tools & Services
SectorHealthcare
SymbolNASDAQ:ILMN
CUSIP45232710
Phone+1-858-2024500

Debt

Debt-to-Equity Ratio0.43%
Current Ratio3.99%
Quick Ratio3.55%

Price-To-Earnings

Trailing P/E Ratio38.4074074074074
Forward P/E Ratio49.93
P/E Growth3.03

Sales & Book Value

Annual Sales$2.75 billion
Price / Sales12.24
Cash Flow$5.32 per share
Price / Cash43.07
Book Value$18.83 per share
Price / Book12.17

Profitability

Trailing EPS$5.94
Net Income$726 million
Net Margins26.56%
Return on Equity21.71%
Return on Assets11.94%

Miscellaneous

Employees6,200
Outstanding Shares147,000,000

Illumina (NASDAQ:ILMN) Frequently Asked Questions

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) posted its quarterly earnings data on Tuesday, January, 30th. The life sciences company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.22 by $0.22. The life sciences company earned $778 million during the quarter, compared to analyst estimates of $752.04 million. Illumina had a net margin of 26.56% and a return on equity of 21.71%. Illumina's revenue was up 25.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.85 EPS. View Illumina's Earnings History.

When will Illumina make its next earnings announcement?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, April, 23rd 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina updated its FY18 earnings guidance on Tuesday, January, 30th. The company provided earnings per share guidance of $4.50-4.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.58. The company issued revenue guidance of $3.10-3.13 billion, compared to the consensus revenue estimate of $3.13 billion.

Where is Illumina's stock going? Where will Illumina's stock price be in 2018?

20 Wall Street analysts have issued 12 month price targets for Illumina's stock. Their forecasts range from $157.00 to $277.00. On average, they expect Illumina's stock price to reach $242.18 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • 1. According to Zacks Investment Research, "Post a promising third-quarter show, we expect Illumina to maintain its growth momentum on continued uptake of sequencing consumables, instruments and microarray portfolios. Management is also hopeful that recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System will drive demand for NovaSeq. We look forward to the launch of NovaSeq Xp workflow. Also, the company’s launch of Nextera DNA Flex buoys optimism. Moreover, the company recently partnered with Telegraph Hill Partners to set up an independent entity. Accordingly, over the last three months, Illumina has been trading above the broader industry. On the flip side, weak margins owing to the NovaSeq launch, higher array services revenues and unfavorable product mix within sequencing consumables will continue to act as deterrents." (12/26/2017)
  • 2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Jay T. Flatley, Executive Chairman of the Board (Age 65)
  • Francis A. deSouza, President, Chief Executive Officer, Director (Age 47)
  • Sam Samad, Chief Financial Officer, Senior Vice President (Age 47)
  • Marc A. Stapley, Executive Vice President, Chief Administrative Officer (Age 46)
  • Garret Hampton Ph.D., Executive Vice President - Clinical Genomics (Age 51)
  • Omead Ostadan, Executive Vice President - Operations, Products and Strategy (Age 45)
  • Mostafa Ronaghi Ph.D., Chief Technology Officer, Senior Vice President (Age 47)
  • Charles E. Dadswell, Senior Vice President, General Counsel, Secretary (Age 57)
  • Aimee Hoyt, Senior Vice President and Chief People Officer
  • Mark Van Oene, Senior Vice President, Chief Commercial Officer

Who owns Illumina stock?

Illumina's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BAILLIE GIFFORD & COMPANY (12.16%), Sands Capital Management LLC (3.26%), Jennison Associates LLC (3.02%), Geode Capital Management LLC (1.08%), TIAA CREF Investment Management LLC (1.06%) and Winslow Capital Management LLC (0.72%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Oene Mark Van, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Sands Capital Management LLC, Baird Financial Group Inc., Winslow Capital Management LLC, Renaissance Technologies LLC, Two Sigma Advisers LP, State Treasurer State of Michigan, Rockefeller Financial Services Inc. and Retirement Systems of Alabama. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van, Omead Ostadan and Robert S Epstein. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was purchased by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Jennison Associates LLC, Assenagon Asset Management S.A., Carillon Tower Advisers Inc., Guggenheim Capital LLC, Arrowstreet Capital Limited Partnership, Teacher Retirement System of Texas and Geode Capital Management LLC. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of Illumina stock can currently be purchased for approximately $229.20.

How big of a company is Illumina?

Illumina has a market capitalization of $33.69 billion and generates $2.75 billion in revenue each year. The life sciences company earns $726 million in net income (profit) each year or $5.94 on an earnings per share basis. Illumina employs 6,200 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 Illumina Way, SAN DIEGO, CA 92122-4616, United States. The life sciences company can be reached via phone at +1-858-2024500 or via email at [email protected]


MarketBeat Community Rating for Illumina (ILMN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  721 (Vote Outperform)
Underperform Votes:  711 (Vote Underperform)
Total Votes:  1,432
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Illumina (NASDAQ:ILMN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.602.502.502.37
Ratings Breakdown: 1 Sell Rating(s)
6 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
8 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
8 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $242.18$220.47$199.28$173.56
Price Target Upside: 9.99% upside8.68% downside2.72% downside12.17% downside

Illumina (NASDAQ:ILMN) Consensus Price Target History

Price Target History for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ:ILMN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/5/2018CitigroupUpgradeNeutral -> Buy$260.00 -> $275.00HighView Rating Details
1/31/2018BarclaysBoost Price TargetEqual Weight -> Equal Weight$200.00 -> $215.00MediumView Rating Details
1/31/2018Morgan StanleyBoost Price TargetUnderweight -> Underweight$145.00 -> $157.00HighView Rating Details
1/31/2018Leerink SwannBoost Price TargetOutperform -> Outperform$250.00 -> $276.00HighView Rating Details
1/31/2018Canaccord GenuityReiterated RatingBuy$255.00 -> $265.00HighView Rating Details
1/31/2018First AnalysisUpgradeEqual Weight -> Overweight$277.00HighView Rating Details
1/22/2018CowenBoost Price TargetOutperform$250.00 -> $275.00LowView Rating Details
1/16/2018BTIG ResearchReiterated RatingHoldLowView Rating Details
1/16/2018Deutsche BankSet Price TargetBuy$275.00MediumView Rating Details
1/9/2018Wells Fargo & CoReiterated RatingOutperform -> Positive$250.00 -> $260.00HighView Rating Details
1/9/2018Piper Jaffray CompaniesReiterated RatingBuy$269.00N/AView Rating Details
1/5/2018William BlairDowngradeOutperform -> Market PerformMediumView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform$250.00LowView Rating Details
10/25/2017Bank of AmericaBoost Price TargetBuy$215.00 -> $240.00N/AView Rating Details
10/25/2017Robert W. BairdUpgradeNeutral -> Outperform$184.00 -> $228.00N/AView Rating Details
10/23/2017Janney Montgomery ScottUpgradeSell -> NeutralN/AView Rating Details
9/26/2017Goldman Sachs GroupReiterated RatingNeutral -> Neutral$200.00LowView Rating Details
9/13/2017ArgusBoost Price TargetBuy$205.00 -> $235.00LowView Rating Details
8/2/2017JPMorgan Chase & Co.Reiterated RatingOverweight$250.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Illumina (NASDAQ:ILMN) Earnings History and Estimates Chart

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/23/2018$1.04N/AView Earnings Details
1/30/2018Q4 2017$1.22$1.44$752.04 million$778.00 millionViewListenView Earnings Details
10/24/2017Q3 2017$0.99$1.11$692.77 million$714.00 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
7/26/2011Q2 2011$0.36$0.38ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
10/26/2010Q3 2010$0.24$0.30ViewN/AView Earnings Details
7/27/2010Q2 2010$0.23$0.26ViewN/AView Earnings Details
4/28/2010Q1 2010$0.19$0.21ViewN/AView Earnings Details
2/4/2010Q4 2009$0.19$0.20ViewN/AView Earnings Details
10/27/2009Q3 2009$0.20$0.17ViewN/AView Earnings Details
7/21/2009Q2 2009$0.18$0.18ViewN/AView Earnings Details
4/21/2009Q1 2009$0.19$0.19ViewN/AView Earnings Details
2/3/2009Q4 2008$0.17$0.24ViewN/AView Earnings Details
10/21/2008Q3 2008$0.17$0.17ViewN/AView Earnings Details
7/22/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
4/22/2008Q1 2008$0.12$0.12ViewN/AView Earnings Details
2/4/2008Q4 2007$0.12$0.15ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Illumina (NASDAQ:ILMN) Earnings Estimates

2018 EPS Consensus Estimate: $4.59
2019 EPS Consensus Estimate: $5.20
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20183$0.88$1.09$1.00
Q2 20183$1.06$1.10$1.07
Q3 20183$1.14$1.26$1.20
Q4 20182$1.25$1.37$1.31
Q1 20192$1.03$1.20$1.12
Q2 20192$1.21$1.22$1.22
Q3 20192$1.37$1.43$1.40
Q4 20192$1.39$1.54$1.47
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Illumina (NASDAQ ILMN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.89%
Institutional Ownership Percentage: 91.12%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Illumina (NASDAQ ILMN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2018Marc StapleyEVPSell2,000$216.87$433,740.0027,952View SEC Filing  
2/5/2018Charles DadswellSVPSell1,610$221.45$356,534.505,581View SEC Filing  
2/1/2018A Blaine BowmanDirectorSell3,000$230.82$692,460.0019,868View SEC Filing  
1/29/2018Robert S EpsteinDirectorSell1,250$244.18$305,225.008,588View SEC Filing  
1/17/2018Marc StapleyEVPSell2,000$242.33$484,660.0029,815View SEC Filing  
1/16/2018Jay T FlatleyDirectorSell15,000$243.72$3,655,800.00449,201View SEC Filing  
1/3/2018Charles DadswellSVPSell145$224.50$32,552.507,411View SEC Filing  
1/2/2018Jay T FlatleyDirectorSell20,000$223.40$4,468,000.00463,436View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.00View SEC Filing  
12/29/2017Robert S EpsteinDirectorSell1,250$217.38$271,725.008,838View SEC Filing  
12/19/2017Jay T FlatleyDirectorSell20,000$215.48$4,309,600.00480,476View SEC Filing  
12/5/2017Jay T FlatleyDirectorSell20,000$212.55$4,251,000.00505,980View SEC Filing  
12/4/2017Charles DadswellSVPSell145$225.33$32,672.856,388View SEC Filing  
12/4/2017Marc StapleyEVPSell2,000$219.88$439,760.0029,198View SEC Filing  
12/1/2017Omead OstadanEVPSell3,540$226.91$803,261.4026,827View SEC Filing  
12/1/2017Robert S EpsteinDirectorSell1,250$226.55$283,187.509,088View SEC Filing  
11/21/2017Jay T FlatleyDirectorSell20,000$211.35$4,227,000.00531,717View SEC Filing  
11/15/2017Marc StapleyEVPSell2,000$205.48$410,960.0030,370View SEC Filing  
11/15/2017Oene Mark VanSVPSell1,250$207.76$259,700.0011,691View SEC Filing  
11/13/2017Oene Mark VanSVPSell1,232$207.78$255,984.9611,691View SEC Filing  
11/7/2017Jay T FlatleyDirectorSell20,000$210.59$4,211,800.00536,717View SEC Filing  
11/3/2017Charles DadswellSVPSell1,609$207.88$334,478.927,217View SEC Filing  
10/26/2017Marc StapleyEVPSell2,000$206.88$413,760.0034,579View SEC Filing  
10/24/2017Jay T FlatleyDirectorSell20,000$210.43$4,208,600.00539,176View SEC Filing  
10/12/2017Oene Mark VanSVPSell1,250$207.21$259,012.50View SEC Filing  
10/10/2017Jay T FlatleyDirectorSell20,000$203.27$4,065,400.00View SEC Filing  
10/3/2017Charles DadswellSVPSell145$202.23$29,323.35View SEC Filing  
9/26/2017Jay T FlatleyDirectorSell20,000$200.16$4,003,200.00539,176View SEC Filing  
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00539,176View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.5724,908View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.0086,725View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.0036,179View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.9015,161View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.0015,161View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40539,176View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60539,176View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00539,176View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.4624,571View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.009,037View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.0037,941View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00534,176View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.0715,777View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.0076,585View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00534,176View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.0039,941View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.5626,242View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00534,176View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.8010,646View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.0018,893View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00534,176View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.0041,341View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.8619,139View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00539,176View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.7510,791View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00519,176View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.258,816View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00534,176View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.0018,004View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00539,176View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.2022,255View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.6310,936View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.0018,704View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.0017,065View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.0029,586View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.0017,065View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.0017,065View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.0016,204View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.727,592View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.1027,949View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.6829,040View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.0018,704View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.0017,065View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.0017,065View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.0052,988View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.0051,492View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.0017,065View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.0017,065View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.0839,900View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.006,924View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.9033,916View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.0017,065View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00508,061View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.007,224View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.0017,065View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.006,853View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00498,061View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00498,061View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.0040,248View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.007,824View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00498,061View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.0020,704View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.2418,976View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.0020,704View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.9020,213View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.006,653View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.0017,424View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.9322,463View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.4424,174View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.0018,615View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.8627,073View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.4129,889View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.0065,660View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.0018,615View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.0042,897View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.0067,544View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00508,061View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.005,800View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00635,840View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.8731,997View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.4254,970View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.0533,738View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00498,061View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.0015,576View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.0030,020View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.0018,615View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00635,840View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.7238,529View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.6666,507View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00500,915View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.4460,576View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.0066,507View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00440,784View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.0014,376View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.001,800View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.8446,476View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00433,423View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00433,423View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.0014,376View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.8441,830View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00433,423View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.5013,648View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.0048,293View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.3059,827View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.0014,376View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00433,423View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.006,935View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00423,793View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00423,793View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00423,793View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.0014,376View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00423,793View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.0040,847View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00424,996View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.0014,376View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00648,840View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00424,996View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00648,840View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.0014,376View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.4058,519View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00424,996View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.0010,419View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.0013,648View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00648,840View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00424,996View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.0013,648View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00381,262View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.0023,146View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.009,196View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.009,924View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.6821,996View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00381,262View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.009,924View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.0028,604View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00381,262View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.009,924View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.0023,146View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.6021,996View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00381,262View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.009,924View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.0028,604View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00381,262View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.009,924View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.0014,620View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.0023,146View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.7021,996View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00381,262View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.0028,519View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.2825,049View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.1429,580View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.6529,580View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.009,196View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.0025,781View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00385,105View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00398,105View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.1621,797View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00399,509View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00399,509View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00399,509View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.0026,740View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.0030,236View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00399,509View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00926,488View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.0026,740View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00399,509View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.0024,559View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.0044,837View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00399,509View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00936,488View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.0024,559View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00399,509View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00941,488View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Illumina (NASDAQ ILMN) News Headlines

Source:
DateHeadline
$742.73 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter$742.73 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - February 18 at 3:32 AM
Q3 2018 EPS Estimates for Illumina, Inc. (ILMN) Lowered by AnalystQ3 2018 EPS Estimates for Illumina, Inc. (ILMN) Lowered by Analyst
www.americanbankingnews.com - February 15 at 10:28 AM
Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN)Q4 2018 EPS Estimates for Illumina, Inc. Lifted by Analyst (ILMN)
www.americanbankingnews.com - February 14 at 1:26 PM
Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2017Illumina Inc (ILMN) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - February 13 at 3:18 PM
Analyzing Abaxis (ABAX) and Illumina (ILMN)Analyzing Abaxis (ABAX) and Illumina (ILMN)
www.americanbankingnews.com - February 9 at 9:10 PM
Marc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) StockMarc Stapley Sells 2,000 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - February 9 at 12:12 AM
Illumina Banks on Strategic Partnerships, Competition Rife - NasdaqIllumina Banks on Strategic Partnerships, Competition Rife - Nasdaq
www.nasdaq.com - February 8 at 3:18 PM
Illumina Banks on Strategic Partnerships, Competition RifeIllumina Banks on Strategic Partnerships, Competition Rife
finance.yahoo.com - February 8 at 3:18 PM
Illumina (ILMN) Rating Increased to Buy at CitigroupIllumina (ILMN) Rating Increased to Buy at Citigroup
www.americanbankingnews.com - February 5 at 9:48 PM
Charles Dadswell Sells 1,610 Shares of Illumina, Inc. (ILMN) StockCharles Dadswell Sells 1,610 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - February 5 at 9:32 PM
Illumina, Inc. (ILMN) Director Sells $692,460.00 in StockIllumina, Inc. (ILMN) Director Sells $692,460.00 in Stock
www.americanbankingnews.com - February 5 at 9:14 PM
Financial Review: Illumina (ILMN) & ResMed (RMD)Financial Review: Illumina (ILMN) & ResMed (RMD)
www.americanbankingnews.com - February 4 at 9:08 PM
Illumina (ILMN) Downgraded by BidaskClub to HoldIllumina (ILMN) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - February 3 at 2:32 PM
Cornell Chases Lucrative Royalties Lost on ‘Secret Side Deals’Cornell Chases Lucrative Royalties Lost on ‘Secret Side Deals’
finance.yahoo.com - February 2 at 3:18 PM
Illumina, Inc. to Post Q1 2018 Earnings of $1.04 Per Share, William Blair Forecasts (ILMN)Illumina, Inc. to Post Q1 2018 Earnings of $1.04 Per Share, William Blair Forecasts (ILMN)
www.americanbankingnews.com - February 2 at 9:10 AM
Illumina, Inc. (ILMN) to Post Q1 2018 Earnings of $0.88 Per Share, Leerink Swann ForecastsIllumina, Inc. (ILMN) to Post Q1 2018 Earnings of $0.88 Per Share, Leerink Swann Forecasts
www.americanbankingnews.com - February 2 at 8:54 AM
Baxter forecasts upbeat 2018; expects more buybacks, dealsBaxter forecasts upbeat 2018; expects more buybacks, deals
www.reuters.com - February 1 at 3:17 PM
William Blair Comments on Illumina, Inc.s Q1 2019 Earnings (ILMN)William Blair Comments on Illumina, Inc.'s Q1 2019 Earnings (ILMN)
www.americanbankingnews.com - February 1 at 2:30 PM
Leerink Swann Research Analysts Reduce Earnings Estimates for Illumina, Inc. (ILMN)Leerink Swann Research Analysts Reduce Earnings Estimates for Illumina, Inc. (ILMN)
www.americanbankingnews.com - February 1 at 9:58 AM
Equities Analysts Issue Forecasts for Illumina, Inc.s Q1 2018 Earnings (ILMN)Equities Analysts Issue Forecasts for Illumina, Inc.'s Q1 2018 Earnings (ILMN)
www.americanbankingnews.com - February 1 at 8:52 AM
Notable Wednesday Option Activity: ILMN, NOC, WDCNotable Wednesday Option Activity: ILMN, NOC, WDC
www.nasdaq.com - February 1 at 5:44 AM
Illumina Keeps the Momentum Going With Solid Fourth-Quarter Earnings GrowthIllumina Keeps the Momentum Going With Solid Fourth-Quarter Earnings Growth
finance.yahoo.com - February 1 at 5:44 AM
Illumina, Inc. (ILMN) Expected to Post Quarterly Sales of $729.77 MillionIllumina, Inc. (ILMN) Expected to Post Quarterly Sales of $729.77 Million
www.americanbankingnews.com - February 1 at 2:24 AM
Morgan Stanley Boosts Illumina (ILMN) Price Target to $157.00Morgan Stanley Boosts Illumina (ILMN) Price Target to $157.00
www.americanbankingnews.com - January 31 at 7:18 PM
Leerink Swann Boosts Illumina (ILMN) Price Target to $276.00Leerink Swann Boosts Illumina (ILMN) Price Target to $276.00
www.americanbankingnews.com - January 31 at 7:18 PM
Illumina (ILMN) Given "Hold" Rating at CitigroupIllumina (ILMN) Given "Hold" Rating at Citigroup
www.americanbankingnews.com - January 31 at 5:34 PM
Illuminas (ILMN) CEO Francis deSouza on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaIllumina's (ILMN) CEO Francis deSouza on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - January 31 at 3:18 PM
Illumina (ILMN) Tops Q4 Earnings & Revenues, Issues Guidance - NasdaqIllumina (ILMN) Tops Q4 Earnings & Revenues, Issues Guidance - Nasdaq
www.nasdaq.com - January 31 at 3:18 PM
3 Stocks to Watch on Wednesday: Illumina, Inc. (ILMN), Juniper Networks, Inc. (JNPR) and Stryker Corporation (SYK) - Investorplace.com3 Stocks to Watch on Wednesday: Illumina, Inc. (ILMN), Juniper Networks, Inc. (JNPR) and Stryker Corporation (SYK) - Investorplace.com
investorplace.com - January 31 at 3:18 PM
Illumina (ILMN) Price Target Raised to $215.00Illumina (ILMN) Price Target Raised to $215.00
www.americanbankingnews.com - January 31 at 2:50 PM
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017 - Business Wire (press release)Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017 - Business Wire (press release)
www.businesswire.com - January 31 at 5:40 AM
Illumina Inc. Reveals Gain In Q4 Earnings - NasdaqIllumina Inc. Reveals Gain In Q4 Earnings - Nasdaq
www.nasdaq.com - January 31 at 5:40 AM
After-Hours Earnings Report for January 30, 2018 : CB, SYK, EA, ILMN, EQR, ALGN, BXP, CA, CHRW, AMD, PKG, FNF - NasdaqAfter-Hours Earnings Report for January 30, 2018 : CB, SYK, EA, ILMN, EQR, ALGN, BXP, CA, CHRW, AMD, PKG, FNF - Nasdaq
www.nasdaq.com - January 31 at 5:40 AM
Earnings Reaction History: Illumina, Inc., 30.0% Follow-Through Indicator, 4.9% Sensitive - NasdaqEarnings Reaction History: Illumina, Inc., 30.0% Follow-Through Indicator, 4.9% Sensitive - Nasdaq
www.nasdaq.com - January 31 at 5:40 AM
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
finance.yahoo.com - January 31 at 5:40 AM
Illumina beats Street 4Q forecastsIllumina beats Street 4Q forecasts
finance.yahoo.com - January 31 at 5:40 AM
Illumina (ILMN) Announces Quarterly  Earnings Results, Beats Estimates By $0.25 EPSIllumina (ILMN) Announces Quarterly Earnings Results, Beats Estimates By $0.25 EPS
www.americanbankingnews.com - January 30 at 9:18 PM
Robert S. Epstein Sells 1,250 Shares of Illumina, Inc. (ILMN) StockRobert S. Epstein Sells 1,250 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - January 30 at 9:16 PM
$1.22 EPS Expected for Illumina, Inc. (ILMN) This Quarter$1.22 EPS Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - January 30 at 9:06 PM
Illumina (ILMN) Issues FY18 Earnings GuidanceIllumina (ILMN) Issues FY18 Earnings Guidance
www.americanbankingnews.com - January 30 at 5:10 PM
Is Illumina Inc’s (NASDAQ:ILMN) Balance Sheet Strong Enough To Weather A Storm?Is Illumina Inc’s (NASDAQ:ILMN) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - January 30 at 3:17 PM
Illumina Q4 Earnings PreviewIllumina Q4 Earnings Preview
finance.yahoo.com - January 30 at 3:17 PM
Illumina, Inc. to Host Earnings CallIllumina, Inc. to Host Earnings Call
finance.yahoo.com - January 30 at 3:17 PM
Why Illumina (ILMN) Might Surprise This Earnings Season - NasdaqWhy Illumina (ILMN) Might Surprise This Earnings Season - Nasdaq
www.nasdaq.com - January 29 at 3:18 PM
Why Illumina (ILMN) Might Surprise This Earnings SeasonWhy Illumina (ILMN) Might Surprise This Earnings Season
finance.yahoo.com - January 29 at 3:18 PM
Illumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by AnalystsIllumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - January 27 at 3:22 PM
Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc. - Business Wire (press release)Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc. - Business Wire (press release)
www.businesswire.com - January 27 at 3:19 PM
Better Buy: Illumina, Inc. vs. RocheBetter Buy: Illumina, Inc. vs. Roche
finance.yahoo.com - January 27 at 3:19 PM
Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.
finance.yahoo.com - January 27 at 5:46 AM
Illumina awarded $26.7M in Harmony patent infringement suitIllumina awarded $26.7M in Harmony patent infringement suit
seekingalpha.com - January 26 at 4:30 PM

SEC Filings

Illumina (NASDAQ:ILMN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Illumina (NASDAQ:ILMN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Illumina (NASDAQ ILMN) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.